29.12.2014 Views

Scheele Award Scheele Committee - Apotekarsocieteten

Scheele Award Scheele Committee - Apotekarsocieteten

Scheele Award Scheele Committee - Apotekarsocieteten

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SCHEELE LECTURERS SINCE 1961<br />

1983 Prof Sir James W. Black, Wellcome<br />

Research Labs., Beckenham, UK<br />

<strong>Scheele</strong> <strong>Award</strong><br />

To commemorate the skills and achievements of the famous<br />

chemist and pharmacist Carl Wilhelm <strong>Scheele</strong>, the Swedish<br />

Academy of Pharmaceutical Sciences has since 1961 appointed<br />

a particularly prominent and internationally renowned<br />

pharmaceutical scientist as the <strong>Scheele</strong> Laureate. The <strong>Scheele</strong><br />

Laureate is awarded a prize of 100 000 SEK, a medal and a<br />

diploma. A special <strong>Scheele</strong> symposium is organised in conjunction<br />

with the event.<br />

<strong>Scheele</strong> <strong>Committee</strong><br />

Björn Lindeke, professor, Swedish Academy of Pharmaceutical<br />

Sciences, Stockholm, Sweden (Chairman)<br />

Märit Johansson, Ph.D., Swedish Academy of Pharmaceutical<br />

Sciences, Stockholm, Sweden (Secretary)<br />

Per Arthursson, professor, University of Uppsala, Sweden<br />

Uli Hacksell, professor, Arcadia, San Diego, USA<br />

Johan Häggblad, Ph.D., Neuronova, Stockholm, Sweden<br />

Sven Jacobsson, professor, AstraZeneca R&D, Södertälje, Sweden<br />

Terje Kalland, professor, Novo Nordisk, Copenhagen, Denmark<br />

1961 Dr Frank L. Rose, ICI, UK<br />

1962 Dr Frank P. Doyle, Beecham<br />

Research Labs., UK<br />

1963 Prof Robert Schwyzer, CIBA,<br />

Switzerland<br />

1964 Dr Lewis H. Sarett, Merck,<br />

Sharp & Dohme, USA<br />

1965 Dr Paul Janssen, Research Labs.,<br />

Belgium<br />

1966 ----<br />

1967 Prof Bernard B. Brodie, National<br />

Institute of Health, USA<br />

1968 Prof Arnold H. Beckett, Chelsea<br />

College of Science and Technology, UK<br />

1969 Prof Takeru Higuchi, University<br />

of Kansas, USA<br />

1970 Dr Norman J. Harper, Winthrop<br />

Labs., UK<br />

1971 Dr Albert Hofmann, Basle,<br />

Switzerland<br />

1972 Prof Carl Djerassi, Stanford<br />

University, San Francisco, USA<br />

1973 Prof Harold N. MacFarland, Bio<br />

Research Lab. Ltd., Quebec, Canada<br />

1974 Prof E. J. Ariens, University of<br />

Nijmegen, The Netherlands<br />

1975 Prof Edward P. Abraham, Oxford<br />

University, UK<br />

1976 Prof Evan C. Horning, Texas<br />

Medical Center, Houston, USA<br />

1977 Prof Hans W. Kosterlitz, University<br />

of Aberdeen, UK<br />

1978 Prof Sidney Riegelman, University<br />

of California, USA<br />

1979 Prof Peter Speiser, ETH, Zürich,<br />

Switzerland<br />

1980 Prof Harri R. Nevanlinna, Finnish<br />

Red Cross, Helsinki, Finland<br />

1981 Prof George K. Aghajanian, Yale<br />

University, New Haven, USA<br />

1984 Prof Malcolm Rowland, University<br />

of Manchester, UK<br />

1985 Prof Stanley S. Davis, University of<br />

Nottingham, UK<br />

1986 Prof Luc Montagnier, Institute of<br />

Pasteur, Paris, France<br />

1987 Prof Roland W. Frei, Free University,<br />

Amsterdam, The Netherlands<br />

1988 Dr David V. Goeddel, Genentech Inc.,<br />

South San Francisco, USA<br />

1989 Prof Dennis V. Parke, University of<br />

Surrey, Guilford, UK<br />

1990 Prof Gerhard Levy, State University<br />

of New York at Buffalo, Amherst, USA<br />

1991 Prof K. Barry Sharpless, MIT,<br />

Cambridge, USA<br />

1992 Prof Koji Nakanishi, Suntory Inst for<br />

Bioorganic Research, Osaka, Japan<br />

1993 Prof Alexander T. Florence, School of<br />

Pharmacy, University of London, UK<br />

1994 Prof Greg Winter, Medical Research<br />

Council, University of Cambridge, UK<br />

1995 Prof Patrik J. Hendra, Dept of<br />

Chemistry, University of Southampton, UK<br />

1996 Prof Gordon L. Amidon, College of<br />

Pharmacy, University of Michigan, USA<br />

1997 Prof Julian E. Davis, University of<br />

British Columbia, Vancouver, Canada<br />

1998 Prof Albert I Wertheimer, Merck &<br />

Co., Inc, West Point, Pennsylvania, USA<br />

1999 Prof John W. Daly, National Institute<br />

of Health, Bethesda, MD, USA<br />

2000 Prof Douwe.D. Breimer, Leiden<br />

University, The Netherlands<br />

2001 Prof. Andrew H. Wyllie, Dept. of<br />

Pathology, University of Cambridge, UK<br />

2002 ----<br />

2003 Prof. Jonathan A. Ellman, Dept of<br />

Chemistry, University of California, USA<br />

2004 ----<br />

THE<br />

SCHEELE<br />

AWARD<br />

1982 Prof Charles Weissmann, University<br />

of Zürich, Switzerland<br />

2005 Prof. Jan van der Greef, Leiden<br />

University & TNO Pharma, The Netherlands<br />

APOTEKARSOCIETETEN<br />

SWEDISH ACADEMY OF<br />

PHARMACEUTICAL SCIENCES


isolated and characterized several organic acids (lactic-, pyrogallic-,<br />

gallic-, oxalic-, citric-, tartaric-, malic-, mucic- and uric<br />

acid). He invented improved processes for preparing calomel,<br />

phosphorus and ether, and, without realizing it, he touched<br />

upon the principle of photography.<br />

In honour of the world-renowned<br />

Swedish chemist and pharmacist Carl<br />

Wilhelm <strong>Scheele</strong> the Swedish Academy<br />

of Pharmaceutical Sciences has since<br />

the year of 1961 bestowed the <strong>Scheele</strong><br />

<strong>Award</strong> to prominent scientists in<br />

the field of drug research or related<br />

disciplines.<br />

Jan van der Greef<br />

The <strong>Scheele</strong> Pharmacy in Köping, Sweden<br />

The <strong>Scheele</strong> <strong>Award</strong> 2005<br />

The dependence of the development of chemistry on pharmacy<br />

is brilliantly illustrated through the career of Carl Wilhelm<br />

<strong>Scheele</strong>. A native of Strahllsund in northern Germany (in<br />

those days a Swedish province), <strong>Scheele</strong> moved to Sweden at<br />

a young age. In the laboratory of his out-of-the-way town of<br />

Köping, <strong>Scheele</strong> eventually finalized many of the experiments<br />

he had begun during his pharmaceutical apprenticeship and<br />

clerkships in Gothenburg, Malmoe, Stockholm and Uppsala.<br />

The amazing number, quality and variety of experiments<br />

performed by <strong>Scheele</strong> in his short life (1742-1786) clearly<br />

show that his devotion to the laboratory exceeded his devotion<br />

to his pharmacy shop. His discoveries were many and<br />

varied. First of all, <strong>Scheele</strong> should be given proper credit for<br />

the discovery of oxygen in the year 1773. Due to a delay in<br />

the publication of his findings and to the relative isolation in<br />

which <strong>Scheele</strong> lived and worked, the discovery of deflogisticated<br />

air has often been accredited to Joseph Priestly. Apart<br />

from oxygen, <strong>Scheele</strong> discovered seven other elements; barium,<br />

chlorine, fluoride, manganese, molybdenum, nitrogen<br />

and tungsten. <strong>Scheele</strong> discovered and characterized ammonia<br />

and a number of inorganic acids (arsenic, tungstic-, molybdic-,<br />

hydrofluoric- and nitrosulfonic acid). He also discovered,<br />

<strong>Scheele</strong>’s Unanswered Letter<br />

In this letter <strong>Scheele</strong>, the apothecary in Uppsala, thanks the French<br />

scientist Lavoisier for his book and tries to establish a collaboration<br />

for the study of oxygen with the well-equipped Lavoisier. Apparently<br />

Lavoisier never replied, even though <strong>Scheele</strong> had gone to the trouble<br />

to have a friend help him render the letter from German into French.<br />

Some say this is evidence that <strong>Scheele</strong> was the first to discover the<br />

existence of Oxygen.<br />

Equipment developed by <strong>Scheele</strong> for the preparation of oxygen.<br />

The <strong>Scheele</strong> <strong>Award</strong> 2005 has been bestowed upon Professor<br />

Jan van der Greef of the TNO Institute, the Netherlands, for<br />

his visionary contributions in the field of pharmaceutical and<br />

biomedical analysis. His research covers the introduction and<br />

use of advanced techniques such as NMR and mass spectrometry<br />

for quantitative purposes, especially in combination<br />

with the development of multivariate statistical tools. In addition,<br />

Prof. van der Greef recently demonstrated the importance<br />

and role of analytical sciences in systems biology.<br />

Prof. van der Greef is a pioneer in the area of drug quantization<br />

and drug metabolism. Technology developments have<br />

played a vital role in a number of clinical studies conducted<br />

under his leadership. As a result of the pharmaceutical scientific<br />

activities of Prof. van der Greef, several small enterprises<br />

have been formed (Kiadis and BG Medicine). These successful<br />

biotech- and biomedical companies have developed expertise<br />

in specific steps of the drug development process. He has also<br />

been able to balance an active academic leadership as professor<br />

at the University of Leiden, the Netherlands, with his role<br />

as a leader of the TNO institute.<br />

The <strong>Scheele</strong> Symposium, this year with the theme Systems<br />

Biology, will be held at the Biotech Forum in Stockholm on<br />

the 11th of October. It is divided into two parts and includes<br />

many eminent and recognized speakers in the field.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!